IMI to revolutionize the hunt for Alzheimer's drugs as part of €371m call
This article was originally published in Scrip
Executive Summary
The Innovative Medicines Initiative (IMI) is launching a €53m collaborative project including 12 big pharma companies with the aim of speeding the development of Alzheimer’s drugs by using an innovative approach to clinical trials. The Alzheimer's project is just one detailed in the IMI’s eleventh call for proposals, which has a total budget of €371m.